Virtus Pharmaceuticals Opco Ii L recalls
FDA enforcement reports naming VIRTUS PHARMACEUTICALS OPCO II L as the recalling firm.
- Recall reports
- 7
- Class I (serious)
- 3
- Most recent report
- Jan 4, 2017
- Jan 4, 2017Virt-Advance Prenatal/Postnatal Softgels, Prescription Folic Acid Containing Dietary Su…Drug · VIRTUS PHARMACEUTICALS OPCO II LcGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.Class III
- Jan 4, 2017Extra-Virt Plus DHA Prenatal/Postnatal Softgel, Prescription Multivitamin/Mineral Dieta…Drug · VIRTUS PHARMACEUTICALS OPCO II LcGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.Class III
- Jan 4, 2017Virt-Select Prenatal/Postnatal Softgels, Prescription Multivitamin/Mineral Dietary Supp…Drug · VIRTUS PHARMACEUTICALS OPCO II LcGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.Class III
- Jan 4, 2017VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and…Drug · VIRTUS PHARMACEUTICALS OPCO II LcGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.Class III
- Dec 28, 2016Hyoscyamine Sulfate, Orally Disintegrating Tablets, 0Drug · VIRTUS PHARMACEUTICALS OPCO II LFailed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.Class I
- Dec 28, 2016Hyoscyamine Sulfate, USP Tablets, 0Drug · VIRTUS PHARMACEUTICALS OPCO II LFailed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.Class I
- Dec 28, 2016Hyoscyamine Sulfate, Sublingual Tablets, 0Drug · VIRTUS PHARMACEUTICALS OPCO II LFailed Content Uniformity Specifications: resulting in both superpotent and subpotent tablets.Class I